Linkage studies in peripheral neurofibromatosis

M. A. Pericak-Vance, L. H. Yamaoka, J. M. Vance, A. S. Aylsworth, G. O D Rossenwasser, P. C. Gaskell, M. J. Alberts, W. Y. Hung, C. Haynes, A. D. Roses

Research output: Contribution to journalArticle

Abstract

Peripheral neurofibromatosis (NF) is one of the most common major genetic disorders in man. Its chromosomal location is unknown and questions regarding such factors as genetic heterogeneity remain unanswered. We have ascertained and sampled several large multi-generation families for linkage studies including one family of 66 subjects, 28 of whom were affected with NF. Recombinant DNA studies of several restriction fragment length polymorphisms (RFLPs) including C3, ApoC2, pBam34 (D19S6], HAUP[APRT], pE40-1[D11521], Hp[Hp2α], LDR92, and LDR111 failed to show a significant linkage (Z[lod score]≥3.00) in this family. In addition, the results excluded areas of the genome around the marker loci (Z≤-2.00) as potential sites for linkage. The maximum Z obtained with the markers was for Hp at Θ (maximum recombination fraction)=0.20 and Z=0.399. We are now in the process of screening additional RFLPs and families for linkage to NF.

Original languageEnglish (US)
Pages (from-to)530-532
Number of pages3
JournalJournal of Medical Genetics
Volume24
Issue number9
StatePublished - 1987

Fingerprint

Neurofibromatosis 1
Neurofibromatoses
Restriction Fragment Length Polymorphisms
Apolipoprotein C-II
Lod Score
Inborn Genetic Diseases
Genetic Heterogeneity
Recombinant DNA
Genetic Recombination
Genome

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Pericak-Vance, M. A., Yamaoka, L. H., Vance, J. M., Aylsworth, A. S., Rossenwasser, G. O. D., Gaskell, P. C., ... Roses, A. D. (1987). Linkage studies in peripheral neurofibromatosis. Journal of Medical Genetics, 24(9), 530-532.

Linkage studies in peripheral neurofibromatosis. / Pericak-Vance, M. A.; Yamaoka, L. H.; Vance, J. M.; Aylsworth, A. S.; Rossenwasser, G. O D; Gaskell, P. C.; Alberts, M. J.; Hung, W. Y.; Haynes, C.; Roses, A. D.

In: Journal of Medical Genetics, Vol. 24, No. 9, 1987, p. 530-532.

Research output: Contribution to journalArticle

Pericak-Vance, MA, Yamaoka, LH, Vance, JM, Aylsworth, AS, Rossenwasser, GOD, Gaskell, PC, Alberts, MJ, Hung, WY, Haynes, C & Roses, AD 1987, 'Linkage studies in peripheral neurofibromatosis', Journal of Medical Genetics, vol. 24, no. 9, pp. 530-532.
Pericak-Vance MA, Yamaoka LH, Vance JM, Aylsworth AS, Rossenwasser GOD, Gaskell PC et al. Linkage studies in peripheral neurofibromatosis. Journal of Medical Genetics. 1987;24(9):530-532.
Pericak-Vance, M. A. ; Yamaoka, L. H. ; Vance, J. M. ; Aylsworth, A. S. ; Rossenwasser, G. O D ; Gaskell, P. C. ; Alberts, M. J. ; Hung, W. Y. ; Haynes, C. ; Roses, A. D. / Linkage studies in peripheral neurofibromatosis. In: Journal of Medical Genetics. 1987 ; Vol. 24, No. 9. pp. 530-532.
@article{40f2217158d4493f89d852b5586fae85,
title = "Linkage studies in peripheral neurofibromatosis",
abstract = "Peripheral neurofibromatosis (NF) is one of the most common major genetic disorders in man. Its chromosomal location is unknown and questions regarding such factors as genetic heterogeneity remain unanswered. We have ascertained and sampled several large multi-generation families for linkage studies including one family of 66 subjects, 28 of whom were affected with NF. Recombinant DNA studies of several restriction fragment length polymorphisms (RFLPs) including C3, ApoC2, pBam34 (D19S6], HAUP[APRT], pE40-1[D11521], Hp[Hp2α], LDR92, and LDR111 failed to show a significant linkage (Z[lod score]≥3.00) in this family. In addition, the results excluded areas of the genome around the marker loci (Z≤-2.00) as potential sites for linkage. The maximum Z obtained with the markers was for Hp at Θ (maximum recombination fraction)=0.20 and Z=0.399. We are now in the process of screening additional RFLPs and families for linkage to NF.",
author = "Pericak-Vance, {M. A.} and Yamaoka, {L. H.} and Vance, {J. M.} and Aylsworth, {A. S.} and Rossenwasser, {G. O D} and Gaskell, {P. C.} and Alberts, {M. J.} and Hung, {W. Y.} and C. Haynes and Roses, {A. D.}",
year = "1987",
language = "English (US)",
volume = "24",
pages = "530--532",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "9",

}

TY - JOUR

T1 - Linkage studies in peripheral neurofibromatosis

AU - Pericak-Vance, M. A.

AU - Yamaoka, L. H.

AU - Vance, J. M.

AU - Aylsworth, A. S.

AU - Rossenwasser, G. O D

AU - Gaskell, P. C.

AU - Alberts, M. J.

AU - Hung, W. Y.

AU - Haynes, C.

AU - Roses, A. D.

PY - 1987

Y1 - 1987

N2 - Peripheral neurofibromatosis (NF) is one of the most common major genetic disorders in man. Its chromosomal location is unknown and questions regarding such factors as genetic heterogeneity remain unanswered. We have ascertained and sampled several large multi-generation families for linkage studies including one family of 66 subjects, 28 of whom were affected with NF. Recombinant DNA studies of several restriction fragment length polymorphisms (RFLPs) including C3, ApoC2, pBam34 (D19S6], HAUP[APRT], pE40-1[D11521], Hp[Hp2α], LDR92, and LDR111 failed to show a significant linkage (Z[lod score]≥3.00) in this family. In addition, the results excluded areas of the genome around the marker loci (Z≤-2.00) as potential sites for linkage. The maximum Z obtained with the markers was for Hp at Θ (maximum recombination fraction)=0.20 and Z=0.399. We are now in the process of screening additional RFLPs and families for linkage to NF.

AB - Peripheral neurofibromatosis (NF) is one of the most common major genetic disorders in man. Its chromosomal location is unknown and questions regarding such factors as genetic heterogeneity remain unanswered. We have ascertained and sampled several large multi-generation families for linkage studies including one family of 66 subjects, 28 of whom were affected with NF. Recombinant DNA studies of several restriction fragment length polymorphisms (RFLPs) including C3, ApoC2, pBam34 (D19S6], HAUP[APRT], pE40-1[D11521], Hp[Hp2α], LDR92, and LDR111 failed to show a significant linkage (Z[lod score]≥3.00) in this family. In addition, the results excluded areas of the genome around the marker loci (Z≤-2.00) as potential sites for linkage. The maximum Z obtained with the markers was for Hp at Θ (maximum recombination fraction)=0.20 and Z=0.399. We are now in the process of screening additional RFLPs and families for linkage to NF.

UR - http://www.scopus.com/inward/record.url?scp=0023281171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023281171&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 530

EP - 532

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 9

ER -